Smith & Nephew SNATS Cash on Hand 2010-2024 | SNN

Smith & Nephew SNATS cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Smith & Nephew SNATS cash on hand for the quarter ending June 30, 2024 was $0.302B, a 76.59% decline year-over-year.
  • Smith & Nephew SNATS cash on hand for 2023 was $0.302B, a 13.71% decline from 2022.
  • Smith & Nephew SNATS cash on hand for 2022 was $0.35B, a 72.87% decline from 2021.
  • Smith & Nephew SNATS cash on hand for 2021 was $1.29B, a 26.79% decline from 2020.
Smith & Nephew SNATS Annual Cash on Hand
(Millions of US $)
2023 $302
2022 $350
2021 $1,290
2020 $1,762
2019 $277
2018 $365
2017 $169
2016 $100
2015 $120
2014 $93
2013 $137
2012 $178
2011 $184
2010 $207
2009 $192
Smith & Nephew SNATS Quarterly Cash on Hand
(Millions of US $)
2023-12-31 $302
2023-06-30 $190
2022-12-31 $350
2022-06-30 $516
2021-12-31 $1,290
2021-06-30 $1,387
2020-12-31 $1,762
2020-06-30 $347
2019-12-31 $277
2019-06-30 $137
2018-12-31 $365
2018-06-30 $99
2017-12-31 $169
2017-06-30 $69
2016-12-31 $100
2015-12-31 $120
2015-06-30 $88
2014-12-31 $93
2014-09-30 $147
2014-06-30 $140
2014-03-31 $182
2013-12-31 $137
2013-09-30 $136
2013-06-30 $101
2013-03-31 $125
2012-12-31 $178
2012-09-30 $445
2012-06-30 $221
2012-03-31 $254
2011-12-31 $184
2011-09-30 $292
2011-06-30 $245
2011-03-31 $256
2010-12-31 $207
2010-09-30 $490
2010-06-30 $360
2010-03-31 $268
2009-12-31 $192
2009-09-30 $217
2009-06-30 $156
2009-03-31 $172
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $11.030B $5.549B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $204.284B 25.22
Stryker (SYK) United States $148.861B 33.55
Boston Scientific (BSX) United States $147.840B 42.50
EssilorLuxottica (ESLOY) France $120.398B 0.00
Medtronic (MDT) Ireland $112.636B 16.73
Lonza Group Ag (LZAGY) Switzerland $46.153B 0.00
Haleon (HLN) United Kingdom $41.736B 27.12
GE HealthCare Technologies (GEHC) United States $39.899B 20.69
ResMed (RMD) United States $36.307B 29.83
Terumo (TRUMY) Japan $28.860B 40.76
Koninklijke Philips (PHG) Netherlands $24.692B 18.90
Zimmer Biomet Holdings (ZBH) United States $21.842B 13.91
Insulet (PODD) United States $19.563B 77.90
Baxter (BAX) United States $16.252B 10.57
Bio-Rad Laboratories (BIO) United States $10.094B 34.30
BellRing Brands (BRBR) United States $9.817B 39.50
Demant (WILYY) Denmark $8.735B 0.00
Lantheus Holdings (LNTH) United States $6.632B 15.41
ICU Medical (ICUI) United States $4.089B 38.93
Prestige Consumer Healthcare (PBH) United States $3.823B 19.01
Haemonetics (HAE) United States $3.684B 17.98
Envista Holdings (NVST) United States $3.623B 26.99
Perrigo (PRGO) Ireland $3.281B 9.66
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
QuidelOrtho (QDEL) United States $2.992B 19.25
GN Store Nord (GNNDY) Denmark $2.797B 17.94
Neogen (NEOG) United States $2.592B 29.88
LeMaitre Vascular (LMAT) United States $2.203B 53.55
AtriCure (ATRC) United States $1.926B 0.00
Green Thumb Industries (GTBIF) United States $1.514B 26.50
InMode (INMD) Israel $1.434B 8.62
AdaptHealth (AHCO) United States $1.368B 9.78
Maravai LifeSciences Holdings (MRVI) United States $1.343B 0.00
BioLife Solutions (BLFS) United States $1.274B 0.00
Owens & Minor (OMI) United States $1.145B 8.95
Curaleaf Holdings (CURLF) Canada $0.903B 0.00
Evolus (EOLS) United States $0.895B 0.00
Phibro Animal Health (PAHC) United States $0.881B 15.54
CeriBell (CBLL) United States $0.833B 0.00
Capricor Therapeutics (CAPR) United States $0.678B 0.00
VAREX IMAGING (VREX) United States $0.572B 25.24
Omeros (OMER) United States $0.538B 0.00
Surmodics (SRDX) United States $0.530B 0.00
Cresco Labs (CRLBF) United States $0.434B 0.00
Verano Holdings (VRNOF) United States $0.418B 0.00
ZimVie (ZIMV) United States $0.391B 32.91
Quanterix (QTRX) United States $0.386B 0.00
Valneva SE (VALN) France $0.376B 0.00
Cerus (CERS) United States $0.336B 0.00
Sanara MedTech (SMTI) United States $0.330B 0.00
Viemed Healthcare (VMD) United States $0.317B 30.11
Biote (BTMD) United States $0.307B 6.73
OraSure Technologies (OSUR) United States $0.290B 19.45
Canopy Growth (CGC) Canada $0.263B 0.00
Zynex (ZYXI) United States $0.261B 54.53
High Tide (HITI) Canada $0.244B 100.33
Sanuwave Health (SNWV) United States $0.233B 3.28
Utah Medical Products (UTMD) United States $0.213B 14.71
Aurora Cannabis (ACB) Canada $0.212B 0.00
Brainsway (BWAY) Israel $0.208B 110.50
Organigram Holdings (OGI) Canada $0.198B 0.00
MacroGenics (MGNX) United States $0.193B 0.00
TerrAscend (TSNDF) Canada $0.153B 0.00
Veru (VERU) United States $0.152B 0.00
TriSalus Life Sciences (TLSI) United States $0.149B 0.00
FitLife Brands (FTLF) United States $0.145B 18.29
Jin Medical (ZJYL) China $0.136B 0.00
Quipt Home Medical (QIPT) United States $0.127B 0.00
Fonar (FONR) United States $0.097B 11.00
Oramed Pharmaceuticals (ORMP) United States $0.093B 0.00
InterCure (INCR) Israel $0.078B 0.00
INLIF (INLF) $0.074B 0.00
Exagen (XGN) United States $0.071B 0.00
Rockwell Medical (RMTI) United States $0.070B 36.33
Apyx Medical (APYX) United States $0.057B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
Cytosorbents (CTSO) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.046B 0.00
Modular Medical (MODD) United States $0.043B 0.00
Safety Shot (SHOT) United States $0.029B 0.00
Nephros (NEPH) United States $0.017B 0.00
Innovative Eyewear (LUCY) United States $0.015B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Allurion Technologies (ALUR) United States $0.008B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Trinity Biotech (TRIB) Ireland $0.006B 0.00
Agape ATP (ATPC) $0.006B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Sharps Technology (STSS) United States $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
United-Guardian (UG) United States $0.000B 14.07
SNDL (SNDL) Canada $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00